These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18828626)

  • 81. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Drug Metab Dispos; 2008 Nov; 36(11):2345-54. PubMed ID: 18725511
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Determination of major human cytochrome P450s activities in 96-well plates using liquid chromatography tandem mass spectrometry.
    Lahoz A; Donato MT; Picazo L; Gómez-Lechón MJ; Castell JV
    Toxicol In Vitro; 2007 Oct; 21(7):1247-52. PubMed ID: 17521862
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Characterization of human liver cytochromes P450 by combining the biochemical and proteomic approaches.
    Petushkova NA; Kanaeva IP; Lisitsa AV; Sheremetyeva GF; Zgoda VG; Samenkova NF; Karuzina II; Archakov AI
    Toxicol In Vitro; 2006 Sep; 20(6):966-74. PubMed ID: 16533590
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Biotransformation of 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878), a novel 5-hydroxytryptamine (5-HT)1A agonist/5-HT3 antagonist, in human hepatic cytochrome P450 enzymes.
    Minato K; Suzuki R; Asagarasu A; Matsui T; Sato M
    Drug Metab Dispos; 2008 May; 36(5):831-40. PubMed ID: 18238859
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cytochrome P450-dependent metabolism of PCB52 in the nematode Caenorhabditis elegans.
    Schäfer P; Müller M; Krüger A; Steinberg CE; Menzel R
    Arch Biochem Biophys; 2009 Aug; 488(1):60-8. PubMed ID: 19563772
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Generalized proteochemometric model of multiple cytochrome p450 enzymes and their inhibitors.
    Kontijevskis A; Komorowski J; Wikberg JE
    J Chem Inf Model; 2008 Sep; 48(9):1840-50. PubMed ID: 18693719
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.
    Ding X; Kaminsky LS
    Annu Rev Pharmacol Toxicol; 2003; 43():149-73. PubMed ID: 12171978
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cytochrome P450 and its role in veterinary drug interactions.
    Trepanier LA
    Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):975-85, v. PubMed ID: 16984823
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?
    Haining RL; Nichols-Haining M
    Pharmacol Ther; 2007 Mar; 113(3):537-45. PubMed ID: 17270273
    [TBL] [Abstract][Full Text] [Related]  

  • 90. In vitro inhibition of multiple cytochrome P450 isoforms by xanthone derivatives from mangosteen extract.
    Foti RS; Pearson JT; Rock DA; Wahlstrom JL; Wienkers LC
    Drug Metab Dispos; 2009 Sep; 37(9):1848-55. PubMed ID: 19541824
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 92. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2009 Sep; 37(9):1938-47. PubMed ID: 19487251
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A cocktail approach for assessing the in vitro activity of human cytochrome P450s: an overview of current methodologies.
    Spaggiari D; Geiser L; Daali Y; Rudaz S
    J Pharm Biomed Anal; 2014 Dec; 101():221-37. PubMed ID: 24746851
    [TBL] [Abstract][Full Text] [Related]  

  • 94. NADPH-dependent metabolism of 17beta-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms.
    Zhu BT; Lee AJ
    Steroids; 2005 Apr; 70(4):225-44. PubMed ID: 15784278
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A medicinal-chemistry-guided approach to selective and druglike sigma 1 ligands.
    Corbera J; Vaño D; Martínez D; Vela JM; Zamanillo D; Dordal A; Andreu F; Hernandez E; Perez R; Escriche M; Salgado L; Yeste S; Serafini MT; Pascual R; Alegre J; Calvet MC; Cano N; Carro M; Buschmann H; Holenz J
    ChemMedChem; 2006 Jan; 1(1):140-54. PubMed ID: 16892345
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cynomolgus monkey CYPs: a comparison with human CYPs.
    Iwasaki K; Uno Y
    Xenobiotica; 2009 Aug; 39(8):578-81. PubMed ID: 19622000
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
    Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
    Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
    [TBL] [Abstract][Full Text] [Related]  

  • 98. In vitro metabolism of isoliquiritigenin by human liver microsomes.
    Guo J; Liu D; Nikolic D; Zhu D; Pezzuto JM; van Breemen RB
    Drug Metab Dispos; 2008 Feb; 36(2):461-8. PubMed ID: 18006650
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Expression of hepatic drug-metabolizing cytochrome p450 enzymes and their intercorrelations: a meta-analysis.
    Achour B; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Aug; 42(8):1349-56. PubMed ID: 24879845
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Serum derived from ulcerative colitis mouse changes the metabolism of the fluorescent substrate by P450 depending on the degree of disease progression.
    Yamamoto R; Muroi K; Imaishi H
    Chem Biol Interact; 2018 Jun; 290():88-98. PubMed ID: 29842871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.